Nobel Biocare relies on T-Systems for global telecommunications

Nobel Biocare Holding AG with its registered office in Zurich has entrusted T-Systems with setting up and operating its international corporate network. In this way, the world market leader in innovative restorative and aesthetic dental solutions is optimising its transnational telecommunications in 40 locations and more efficiently controlling its production capacities. In addition to smooth communication, the network also offers protection against unauthorised access and secures the flow of information. For further branches continuous connection to the existing network is provided.

T-Systems’ IT-based corporate network will manage Nobel Biocare’s global telecommunications. The company is relying on the Internet protocol (IP) to continuously transport speech and data worldwide on a single platform. This includes, for example, key services like e-mail, and protection against computer viruses. In addition, bandwidths can be provided as needed and the network can be tailored at any time to the business development of the sites and regional circumstances.

All of the data services will run via the standardised communications infrastructure. Using MPLS (Multi Protocol Label Switching) technology, Nobel Biocare can flexibly determine which business-critical applications have priority in the network and make optimal use of the network’s bandwidth. The safety of the entire network is constantly ensured by the central administration of gateways with spam and virus protection along with T-Systems’ proactive system surveillance.

"The order from the medical technology firm Nobel Biocare demonstrates that our high performance network is valued on the market – not least thanks to our modular price structure," says René Mulder, Corporate Customers Director and Executive Board Member at T-Systems in Switzerland.

Emhart Glass, Alpiq, and the automotive supplier Bosch and Siemens, to name just a few, also depend along with Nobel Biocare on MPLS technology from T-Systems. In Switzerland, T-Systems serves other customers in the health care sector in addition to Nobel Biocare, such as clinics, health insurance and pharmacies. 

About T-Systems

Drawing on a global infrastructure of data centers and networks, T-Systems operates information and communication technology (ICT) systems for multinational corporations and public sector institutions. On this basis, Deutsche Telekom’s corporate customer arm provides integrated solutions for the networked future of business and society. Some 46,000 employees at T-Systems combine industry expertise and ICT innovations to add significant value to customers’ core business all over the world. The corporate customers unit generated revenue of around EUR 9.3 billion in the 2008 financial year.

T-Systems has over 900 employees and is represented at sites nationwide in addition to its head office in Zollikofen.

About Nobel Biocare

Nobel Biocare is an innovative medical technology firm that is a world leader in the field of restorative and aesthetic dental solutions. Nobel Biocare employs over 2,300 members of staff across the globe and generated a turnover of 619.2 million euros in 2008. The company’s registered office and operational headquarters are in Zurich. Production takes place at six locations in Sweden, the USA, Japan and Israel. Nobel Biocare has dedicated sales organisations in 37 countries. The parent company Nobel Biocare Holding AG is listed on the Swiss stock exchange SIX (ticker symbol: NOBN).

Contact:

T-Systems
Barbara Melzl
Tel.: +41 78 905 06 15
E-mail: barbara.melzl@t-systems.ch

Further information for journalists: www.t-systems.ch/presse